Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

@article{Cooperberg2009RiskAA,
  title={Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.},
  author={Matthew R. Cooperberg and Shiro Hinotsu and Mikio Namiki and Katsuhide Ito and Jeanette M Broering and Peter R. Carroll and Hideyuki Akaza},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 26},
  pages={
          4306-13
        }
}
PURPOSE Prostate cancer epidemiology has been marked overall by a downward risk migration over time. However, in some populations, both in the United States and abroad, many men are still diagnosed with high-risk and/or advanced disease. Primary androgen deprivation therapy (PADT) is frequently offered to these patients, and disease risk prediction is not well-established in this context. We compared risk features between large disease registries from the United States and Japan, and aimed to… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 61 CITATIONS

FILTER CITATIONS BY YEAR

2010
2018

CITATION STATISTICS

  • 17 Highly Influenced Citations

  • Averaged 6 Citations per year over the last 3 years

  • 11% Increase in citations per year in 2018 over 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Similar Papers

Loading similar papers…